BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sawa M, Overk C, Becker A, Derse D, Albay R, Weldy K, Salehi A, Beach TG, Doran E, Head E, Yu YE, Mobley WC. Impact of increased APP gene dose in Down syndrome and the Dp16 mouse model. Alzheimers Dement 2021. [PMID: 34757693 DOI: 10.1002/alz.12463] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Tramutola A, Lanzillotta S, Aceto G, Pagnotta S, Ruffolo G, Cifelli P, Marini F, Ripoli C, Palma E, Grassi C, Di Domenico F, Perluigi M, Barone E. Intranasal Administration of KYCCSRK Peptide Rescues Brain Insulin Signaling Activation and Reduces Alzheimer's Disease-like Neuropathology in a Mouse Model for Down Syndrome. Antioxidants (Basel) 2023;12. [PMID: 36670973 DOI: 10.3390/antiox12010111] [Reference Citation Analysis]
2 Chen X, Zuo X, Becker A, Head E, Mobley WC. Reduced synaptic proteins and SNARE complexes in Down syndrome with Alzheimer's disease and the Dp16 mouse Down syndrome model: Impact of APP gene dose. Alzheimer's & Dementia 2022. [DOI: 10.1002/alz.12835] [Reference Citation Analysis]
3 Hopkins PCR, Troakes C, King A, Tear G. TMCC2 Associates with Alzheimer’s Disease Pathology in the Human Brain.. [DOI: 10.1101/2021.08.14.456332] [Reference Citation Analysis]